These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7984256)

  • 1. Subcellular localization and cellular pharmacokinetics of MX2, a new morpholino anthracycline in glioma cells using confocal laser scanning microscopy.
    Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Arai Y; Kitai R
    Neurol Res; 1994 Aug; 16(4):257-64. PubMed ID: 7984256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antitumor effect of MX2, a new morpholino anthracycline, against malignant glioma cell lines and its subcellular distribution.
    Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R
    Neurosurgery; 1995 Sep; 37(3):471-6; discussion 476-7. PubMed ID: 7501112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T
    Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats].
    Kiya K; Ogasawara H; Fujita H; Sugiyama K; Kurisu K; Kawamoto K; Uozumi T; Shinkai H
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):631-5. PubMed ID: 8470921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor effect of MX2, a new morpholino anthracycline against C6 glioma cells and its combination effect with photodynamic therapy in vitro].
    Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R; Uno H; Kodera T
    No To Shinkei; 1995 Oct; 47(10):969-73. PubMed ID: 7577142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks.
    Horichi N; Tapiero H; Sugimoto Y; Bungo M; Nishiyama M; Fourcade A; Lampidis TJ; Kasahara K; Sasaki Y; Takahashi T
    Cancer Res; 1990 Aug; 50(15):4698-701. PubMed ID: 2164445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the cytotoxicity of the morpholino anthracycline MX2 against glioma cells in vitro.
    Park SJ; Kaye AH; Hill JS
    J Clin Neurosci; 2000 Jan; 7(1):42-7. PubMed ID: 10847650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination effect of hyperthermia and MX2 on cultured glioma cell lines].
    Mizumatsu S; Ono Y; Tamiya T; Matsumoto K; Ohmoto T; Furuta T
    Gan To Kagaku Ryoho; 1999 May; 26(6):789-95. PubMed ID: 10410148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor effect of a new anthracycline derivative, MX2, against human glioma cells].
    Kuratsu J; Mihara Y; Kochi M; Takaki S; Ushio Y
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):399-403. PubMed ID: 2930204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance.
    Takeda Y; Nishio K; Sugimoto Y; Kasahara K; Kubo S; Fujiwara Y; Niitani H; Saijo N
    Int J Cancer; 1991 Jul; 48(6):931-7. PubMed ID: 1677641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
    Watanabe M; Komeshima N; Nakajima S; Tsuruo T
    Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumour effect of MX2, a new morpholino anthracycline against C6 glioma cells and its cytotoxic effect in combination with photodynamic therapy.
    Kabuto M; Kaye AH; Hill JS; Stylli SS
    J Clin Neurosci; 1994 Jan; 1(1):47-52. PubMed ID: 18638726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of KRN8602, a new morpholino anthracycline, and adriamycin in tumor-bearing mice.
    Shinkai H; Takahashi H; Miyamoto K; Uchida T; Tokiwa T
    Cancer Chemother Pharmacol; 1996; 38(5):417-24. PubMed ID: 8765434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of MX2, a new morpholino anthracycline, against experimental brain tumors.
    Izumoto S; Arita N; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Ushio Y
    Anticancer Res; 1990; 10(3):735-9. PubMed ID: 2369088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of MX2, a new morpholino anthracycline, in CSF following intravenous injection].
    Yamamoto H; Arita N; Ohnishi T; Hiraga S; Izumoto S; Taki T; Higuchi M; Hayakawa T; Shinkai H
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1227-30. PubMed ID: 8333749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution and acute toxicity of a new morpholinoanthracycline, MX2, in normal rat brain after intra-arterial injection].
    Izumoto S; Arita N; Hayakawa T; Ohnishi T; Hiraga S; Taki T; Yamamoto H
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):371-5. PubMed ID: 2003739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of MX2 hydrochloride in patients with advanced malignant disease.
    Morgan DJ; Hill JS; Clarke K; Stylli SS; Park SJ; Cebon J; Basser RL; Kaye AH; Geldard H; Maher DW; Green MD
    Cancer Chemother Pharmacol; 1997; 40(3):202-8. PubMed ID: 9219502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of filgrastim on the pharmacokinetics of MX2 hydrochloride in patients with advanced malignant disease.
    Morgan DJ; Hill JS; Clarke K; Stylli SS; Park SJ; Cebon J; Basser RL; Kaye AH; Geldard H; Maher DW; Green MD
    Cancer Chemother Pharmacol; 1998; 41(5):423-6. PubMed ID: 9523740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of the morpholino anthracycline 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin (MX2) against human tumor colony-forming units in vitro.
    Ebrahim el-Zayat AA; Izquierdo MA; Clark GM; Von Hoff DD
    Invest New Drugs; 1995; 13(2):125-131. PubMed ID: 8617574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.
    Coley HM; Amos WB; Twentyman PR; Workman P
    Br J Cancer; 1993 Jun; 67(6):1316-23. PubMed ID: 8099807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.